Novartis announces positive result of phase III study with radioligand therapy 177Lu-PSMA-617 in patients with advanced prostate cancer
» Report
Einige Inhalte dieser Seite sind nur für Abonnenten sichtbar.
Anmelden oder
Jetzt abonnieren!
Archiv: Alle Kategorien
Zehnder Group startet Aktienrückkaufprogramm zum Zweck der Kapitalherabsetzung
» Report
Roche launches new high throughput configurations for cobas pro integrated solutions to increase testing efficiency
» Report
Roche: New phase III data shows investigational antibody cocktail casirivimab and imdevimab reduced hospitalisation or death by 70% in non-hospitalised patients with COVID-19
» Report
SGS AGM: All Resolutions Approved
» Report
Health Canada Revises Industry Guide for Food Contact Glazed Ceramics and Glassware
» Report
Significant Changes to the Signage for Packaging and Recyclable Products
» Report
SGS Lab Becomes First in Sri Lanka to be Accredited to Test 300 Pesticides
» Report
SGS: Enabling a Better, Safer and More Interconnected World Through World Class Services
» Report
SGS: South Korea Proposes to Strengthen Phthalates Under its Safety Standard for Children’s Products
» Report
IGEA announces three new board members
» Report
IGEA calls extraordinary general meeting
» Report
Roche provides update on tominersen programme in manifest Huntington’s disease
» Report
Übernahmekommission: ams AG
» Report
Sunrise Communications Group: Cancellation of publicly held Sunrise shares
» Report
MEDIA RELEASE: Forbo launches share buyback program 2019–2022 via second trading line
» Report
MEDIENMITTEILUNG: Forbo lanciert Aktienrückkaufsprogramm 2019–2022 über zweite Handelslinie
» Report
Orascom Development Holding AG announces change in its Executive Management Team
» Report
Orascom Development Holding AG kündigt Änderungen in der Geschäftsleitung an
» Report
WISeKey $WKEY Selected by Billon Group to Provide MPKI Services Allowing Trusted Remote Document Signing with Blockchain Technologies
» Report
